Trivalent Subunit Inactivated Influenza Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Trivalent Subunit Inactivated Influenza Vaccine, covering 2011-12-14 to 2014-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age [Phase 3]